Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease precocious puberty
Phenotype C0242292|mccune-albright syndrome
Sentences 3
PubMedID- 22999294 The objective of this study was to evaluate the safety and efficacy of fulvestrant (faslodextm), a pure estrogen receptor antagonist, in girls with progressive precocious puberty (pp) associated with mccune-albright syndrome (mas).
PubMedID- 23087851 Central precocious puberty may be associated with mccune-albright syndrome and neurofibromatosis type-1 (nf-1).
PubMedID- 22051789 Three atypical cases of suspected mccune-albright syndrome with gonadotropin-independent precocious puberty are presented.

Page: 1